Slide Insurance Holdings reports Q2 results this morning with short sellers more committed than they were even 24 hours ago — and the stock 12% higher than a month ago.
Short interest has continued its climb since yesterday's preview. It now stands at 6.3% of the free float, up 26% on the week and 32% over the past month. The acceleration is notable: most of the weekly jump landed in a single session around July 23-24, when shorts added roughly 1.4 million shares in one day. Yet the borrow market offers no sign of stress. Availability remains loose at 489% — meaning roughly five shares are available to borrow for every one already lent out, well above the 52-week floor of 180%. Cost to borrow is a negligible 0.54%. Shorts are adding aggressively, but on favorable terms and without any squeeze pressure building in the lending pool. Options traders are equally unbothered: the put/call ratio of 0.53 sits barely above its 20-day average of 0.51, with a z-score of just 0.4, suggesting no broad defensive hedging into the print.
The analyst picture heading into today's release has diverged. Morgan Stanley downgraded the stock to Equal-Weight on July 6, cutting its target from $23 to $20 — currently the most bearish call among recent movers, and one that sits below the current price of $21.40. Barclays trimmed its target from $31 to $27 on July 7 but held its Overweight rating. Keefe, Bruyette & Woods moved in the opposite direction, lifting its target to $24 while maintaining Outperform. The consensus mean target of $24 implies modest upside from here. The bear case centers on reinsurance cost exposure in catastrophe-prone coastal markets — a risk that could crimp the gross written premium growth that has defined the bull thesis. Bulls point to an 89% CAGR in gross premiums from 2022 to 2024 and favorable Florida legislative reforms as structural tailwinds.
Institutional flows add an interesting wrinkle. BlackRock added nearly 2.5 million shares in the most recent quarter, and American Century added 1.2 million. Against that, founder and CEO Bruce Lucas trimmed 9,000 shares on June 30 after receiving a stock award of the same size — a wash in net terms. Director Robert Gries sold over 112,000 shares across two sessions on July 6-7 for combined proceeds of roughly $2.3 million, a more meaningful disposal. Net insider activity over the past 90 days is positive in share terms due to awards, but the open-market selling pattern is one-sided. Peer performance on the week has also been mixed: HCI fell 2.1%, while UVE surged 10.6% and ASIC gained 5%.
Today's print will test whether the rapid premium growth story can hold up against the reinsurance cost trajectory that the bears — and now Morgan Stanley — have singled out as the central vulnerability.
See the live data behind this article on ORTEX.
Open SLDE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
